Φορτώνει......
Uveal Effusion After Immune Checkpoint Inhibitor Therapy
IMPORTANCE: Immune checkpoint inhibitors, including antiprogrammed cell death protein-1 (anti-PD-1) and antiprogrammed cell death ligand-1 (anti-PD-L1) monoclonal antibodies, have recently been introduced as a promising new immunotherapy for solid cancers. The adverse effects typically include infla...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | JAMA Ophthalmol |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Medical Association
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6145660/ https://ncbi.nlm.nih.gov/pubmed/29677240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2018.0920 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|